Risk adjusted net present value: What is the current valuation of Incyte’s Epacadostat?

Epacadostat is a small molecule commercialized by Incyte, with a leading Phase II program in Salivary Gland Cancer.

Researchers identify new biomarker to predict neuronal regeneration after injury

Neurons, the main cells that make up our brain and spinal cord, are among the slowest cells to regenerate after an injury, and many neurons

October 16, 2023

Infertile men more likely to have impaired kidney function, study says

Study reveals that childless men are more likely to have decreased renal function and proteinuria than fathers, suggesting an association between male infertility and higher

April 4, 2024

What Should Be Done About Long-Term Care?

The problem of how to pay for long-term care continues to bedevil policy experts, with some arguing for a combination public-private insurance market and others

June 26, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.